Toronto-based ​digital health firm BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot’s outbreak risk platform tracks over 150 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, hospitals, and businesses to better anticipate, and respond to, emerging threats. BlueDot was among the first in the world to identify the emerging risk from, and publish a scientific paper on, COVID-19, and delivers regular critical Insights to its partners and customers worldwide to mobilize timely, effective, efficient, coordinated, and measured responses.

BlueDot recognized the emergence of high rates of pneumonia in China nine days before the World Health Organization, and was originally founded in response to the SARS epidemic. It uses natural language processing (NLP) to skim the text of hundreds of thousands of sources to scour news and public statements about the health of humans or animals.

Company Type: Enterprise

Region: US & Canada

Industry Category: Healthcare Biological Sciences Technology Covid 19 Natural Language Processing

Product: Infectious Disease Outbreaks Software